Y-mAbs

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Y-mAbs and buy or sell other stocks, ETFs, and their options commission-free!

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. 

CEO
Michael Rossi
CEOMichael Rossi
Employees
107
Employees107
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2015
Founded2015
Employees
107
Employees107

YMAB Key Statistics

Market cap
391.22M
Market cap391.22M
Price-Earnings ratio
-17.40
Price-Earnings ratio-17.40
Dividend yield
Dividend yield
Average volume
128.38K
Average volume128.38K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$16.11
52 Week high$16.11
52 Week low
$3.55
52 Week low$3.55

Stock Snapshot

Y-mAbs(YMAB) stock is priced at $8.61, giving the company a market capitalization of 391.22M. It carries a P/E multiple of -17.40.

Y-mAbs(YMAB) stock opened on 2026-02-09 at —. The price climbed to — and dipped to —.

The Y-mAbs(YMAB)'s current trading volume is 0, compared to an average daily volume of 128.38K.

In the last year, Y-mAbs(YMAB) shares hit a 52-week high of $16.11 and a 52-week low of $3.55.

In the last year, Y-mAbs(YMAB) shares hit a 52-week high of $16.11 and a 52-week low of $3.55.

People also own

Based on the portfolios of people who own YMAB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.